Rosiou, K.; Ong Ming San, E.; Kumar, A.; Esquivel, K.; Almas, S.; Stokes, D.; Ng, T.; Jayasooriya, N.; Ranasinghe, I.; Pollok, R.;
et al. Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study. J. Clin. Med. 2021, 10, 4329.
https://doi.org/10.3390/jcm10194329
AMA Style
Rosiou K, Ong Ming San E, Kumar A, Esquivel K, Almas S, Stokes D, Ng T, Jayasooriya N, Ranasinghe I, Pollok R,
et al. Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study. Journal of Clinical Medicine. 2021; 10(19):4329.
https://doi.org/10.3390/jcm10194329
Chicago/Turabian Style
Rosiou, Konstantina, Elaine Ong Ming San, Aditi Kumar, Kim Esquivel, Saima Almas, Daniel Stokes, Tze Ng, Nishani Jayasooriya, Ian Ranasinghe, Richard Pollok,
and et al. 2021. "Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study" Journal of Clinical Medicine 10, no. 19: 4329.
https://doi.org/10.3390/jcm10194329
APA Style
Rosiou, K., Ong Ming San, E., Kumar, A., Esquivel, K., Almas, S., Stokes, D., Ng, T., Jayasooriya, N., Ranasinghe, I., Pollok, R., Brookes, M., & Selinger, C. P.
(2021). Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study. Journal of Clinical Medicine, 10(19), 4329.
https://doi.org/10.3390/jcm10194329
